Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 108 | 103 | −5 |
| Shares | 13.6M | 10.2M | −3.43M (−25.2%) |
| Value | $22.2M | $20.7M | −$1.47M (−6.6%) |
New holders (23)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 346,865 | $705.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 171,561 | $349.1K | 0.00% |
| Citadel Advisors LLC | 168,956 | $343.8K | 0.00% |
| Gsa Capital Partners LLP | 163,260 | $332.0K | 0.02% |
| Qube Research & Technologies Ltd | 115,164 | $234.4K | 0.00% |
| HRT Financial LP | 72,222 | $146.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 42,171 | $85.8K | 0.00% |
| Virtu Financial LLC | 38,482 | $78.0K | 0.00% |
| Jain Global LLC | 37,601 | $76.5K | 0.00% |
| Squarepoint Ops LLC | 32,572 | $66.3K | 0.00% |
| HSBC Holdings PLC | 26,075 | $55.9K | 0.00% |
| Two Sigma Securities, LLC | 23,003 | $46.8K | 0.01% |
| Point72 Asia (Singapore) Pte. Ltd. | 17,886 | $36.4K | 0.01% |
| Catalyst Funds Management Pty Ltd | 17,000 | $34.6K | 0.01% |
| Point72 (DIFC) Ltd | 2,600 | $5.29K | 0.00% |
| Raymond James Financial Inc | 371 | $755 | 0.00% |
| Headlands Technologies LLC | 338 | $688 | 0.00% |
| Northwestern Mutual Wealth Management Co | 38 | $77 | 0.00% |
| Strategic Wealth Partners, Ltd. | 29 | $59 | 0.00% |
| True Wealth Design, LLC | 15 | $31 | 0.00% |
| Key Financial Inc | 14 | $28 | 0.00% |
| Johnson Financial Group, Inc. | 8 | $17 | 0.00% |
| Ameritas Advisory Services, LLC | 2 | $4 | 0.00% |
Sold out (28)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.